Jack Kain

Today’s podcast will cover dangerous drug combinations and the role of clinical drug monitoring. Some of the key information that will be shared includes:
What are dangerous drug combinations
What practitioners and the public need to know about them
How dangerous drug combinations can work together to lead to side effects
Certain combinations predispose people to a greater risk of overdose and death
Combinations that can affect drug levels, creating a pharmacokinetic drug–drug interaction
Certain combinations that may result in excessive sedation
How drug testing can help
A tool to identify dangerous drug combinations
How drug testing identifies metabolites unique to a substance
This episode features Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. 

The podcast will cover screening (drug testing) for alcohol use in pain management and primary care. Topics covered will include:
Understand drug and alcohol misuse and abuse
Prevalence rates of alcohol use and misuse, and alcohol use disorders
Information on alcohol use, and concomitant use with opioids and benzodiazepines
Screening guidelines
Tools and types of tests
Testing for alcohol
Breathalyzer
Advances in testing
Biomarkers
Other considerations
Quest Diagnostics approach
This episode features Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. 

Today’s episode is on patients with substance use disorders in medication-assisted treatment (MAT). Some of the key points that will be covered include:
What is medication-assisted treatment
What are the goals of an MAT treatment program
Medications used in MAT treatment 
Drug testing during MAT
Purpose of drug testing
Types of drug testing
Specimen collection
Specimen validity
Test confirmation
This episode features Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. 

Today, we will be talking about marijuana and marijuana-based products in order to: 
Understand drug testing for marijuana, and why it’s important
Examine marijuana used in concert with controlled medications for pain or ADHD
Give some general recommendations for therapeutic drug monitoring for marijuana in patients with chronic pain using controlled substances
For example, at a minimum such patients should be tested before opioid therapy begins, again within 1 to 3 months, and randomly over the next 12 months, and more frequently if there are unexpected results, or there are complaints or behavior changes in the patient 
The episode features Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. They will be discussing drug testing your patients for marijuana.